PL374777A1 - Kompozycje farmaceutyczne, zawierające połączeniekalcytriolu i propionianu klobetazolu - Google Patents

Kompozycje farmaceutyczne, zawierające połączeniekalcytriolu i propionianu klobetazolu

Info

Publication number: PL374777A1
Authority: PL; Poland
Prior art keywords: calcitriol; clobetasol propionate; combination; pharmaceutical compositions; dermatitis
Prior art date: 2002-12-17

Application number

PL03374777A

Other languages

English (en)

Inventor

Andre Jomard

Olivier Roye

Original Assignee

Galderma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-17

Filing date

2003-12-11

Publication date

2005-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32598899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL374777(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-12-17 Priority claimed from FR0216016A external-priority patent/FR2848454B1/fr

2003-12-11 Application filed by Galderma Sa filed Critical Galderma Sa

2005-10-31 Publication of PL374777A1 publication Critical patent/PL374777A1/pl

Links

GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 title abstract 2
229960005084 calcitriol Drugs 0.000 title abstract 2
235000020964 calcitriol Nutrition 0.000 title abstract 2
239000011612 calcitriol Substances 0.000 title abstract 2
229960004703 clobetasol propionate Drugs 0.000 title abstract 2
CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
206010012438 Dermatitis atopic Diseases 0.000 abstract 1
206010012442 Dermatitis contact Diseases 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract 1
201000008937 atopic dermatitis Diseases 0.000 abstract 1
208000010247 contact dermatitis Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
239000008250 pharmaceutical cream Substances 0.000 abstract 1
239000008252 pharmaceutical gel Substances 0.000 abstract 1
239000008336 pharmaceutical lotion Substances 0.000 abstract 1
239000003186 pharmaceutical solution Substances 0.000 abstract 1
208000008742 seborrheic dermatitis Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL03374777A 2002-12-17 2003-12-11 Kompozycje farmaceutyczne, zawierające połączeniekalcytriolu i propionianu klobetazolu PL374777A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0216016A FR2848454B1 (fr)	2002-12-17	2002-12-17	Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
US43705702P	2002-12-31	2002-12-31

Publications (1)

Publication Number	Publication Date
PL374777A1 true PL374777A1 (pl)	2005-10-31

Family

ID=32598899

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03374777A PL374777A1 (pl)	2002-12-17	2003-12-11	Kompozycje farmaceutyczne, zawierające połączeniekalcytriolu i propionianu klobetazolu

Country Status (13)

Country	Link
US (1)	US20060009426A1 (pl)
EP (1)	EP1575598B8 (pl)
JP (1)	JP2006511545A (pl)
KR (1)	KR20050085787A (pl)
AT (1)	ATE374614T1 (pl)
AU (1)	AU2003294027B2 (pl)
BR (1)	BR0315195A (pl)
CA (1)	CA2505406A1 (pl)
DE (1)	DE60316724T2 (pl)
MX (1)	MXPA05003805A (pl)
PL (1)	PL374777A1 (pl)
RU (1)	RU2361594C2 (pl)
WO (1)	WO2004054588A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2871694B1 (fr) *	2004-06-17	2008-07-04	Galderma Sa	Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871696B1 (fr) *	2004-06-17	2006-11-10	Galderma Sa	Composition topique pour le traitement du psoriasis
FR2871699A1 (fr) *	2004-06-17	2005-12-23	Galderma Sa	Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871693B1 (fr) *	2004-06-17	2006-08-25	Galderma Sa	Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2909284B1 (fr) *	2006-11-30	2012-09-21	Galderma Sa	Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
CA2739376A1 (en)	2008-10-03	2010-04-08	Nexmed Holdings, Inc.	Stabilized composition for treating psoriasis
FR2939041A1 (fr) *	2008-11-28	2010-06-04	Natura Cosmeticos Sa	Melange hydratant, compositions cosmetiques et/ou pharmaceutiques le contenant et utilisation et methode de traitement cosmetique mettant en oeuvre ce melange
EP2579852B1 (en)	2010-06-11	2014-12-31	Leo Pharma A/S	A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2017037663A1 (en)	2015-09-02	2017-03-09	Cadila Healthcare Limited	Topical compositions comprising corticosteroids
PT4255442T (pt) *	2020-12-04	2025-05-19	Incyte Corp	Inibidor de jak com um análogo da vitamina d para o tratamento de doenças da pele
US12642802B2 (en)	2021-12-03	2026-06-02	Incyte Corporation	Topical formulations of ruxolitinib with an organic amine pH adjusting agent for treatment of skin diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4610978A (en) *	1983-03-22	1986-09-09	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
RO118174B1 (ro) *	1997-08-21	2003-03-28	Aventis Pharma Deutschland Gmbh	Lac de unghii şi utilizarea acestuia
US5972920A (en) *	1998-02-12	1999-10-26	Dermalogix Partners, Inc.	Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
CN1173703C (zh) *	1999-04-23	2004-11-03	里奥药物制品有限公司	药物组合物
US6524594B1 (en) *	1999-06-23	2003-02-25	Johnson & Johnson Consumer Companies, Inc.	Foaming oil gel compositions
WO2002034235A1 (en) *	2000-10-27	2002-05-02	Leo Pharma A/S	Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid

2003
- 2003-12-11 PL PL03374777A patent/PL374777A1/pl not_active Application Discontinuation
- 2003-12-11 AT AT03789441T patent/ATE374614T1/de not_active IP Right Cessation
- 2003-12-11 JP JP2004560485A patent/JP2006511545A/ja active Pending
- 2003-12-11 BR BR0315195-6A patent/BR0315195A/pt not_active IP Right Cessation
- 2003-12-11 MX MXPA05003805A patent/MXPA05003805A/es active IP Right Grant
- 2003-12-11 RU RU2005122466/15A patent/RU2361594C2/ru not_active IP Right Cessation
- 2003-12-11 WO PCT/EP2003/015011 patent/WO2004054588A1/en not_active Ceased
- 2003-12-11 EP EP03789441A patent/EP1575598B8/en not_active Revoked
- 2003-12-11 AU AU2003294027A patent/AU2003294027B2/en not_active Ceased
- 2003-12-11 CA CA002505406A patent/CA2505406A1/en not_active Abandoned
- 2003-12-11 DE DE60316724T patent/DE60316724T2/de not_active Revoked
- 2003-12-11 KR KR1020057011398A patent/KR20050085787A/ko not_active Ceased
2005
- 2005-06-17 US US11/154,706 patent/US20060009426A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2505406A1 (en)	2004-07-01
DE60316724T2 (de)	2008-07-17
AU2003294027A1 (en)	2004-07-09
WO2004054588A1 (en)	2004-07-01
EP1575598A1 (en)	2005-09-21
MXPA05003805A (es)	2005-06-08
DE60316724D1 (de)	2007-11-15
EP1575598B1 (en)	2007-10-03
KR20050085787A (ko)	2005-08-29
US20060009426A1 (en)	2006-01-12
ATE374614T1 (de)	2007-10-15
AU2003294027B2 (en)	2009-09-10
RU2361594C2 (ru)	2009-07-20
EP1575598B8 (en)	2007-11-21
JP2006511545A (ja)	2006-04-06
RU2005122466A (ru)	2006-01-20
BR0315195A (pt)	2005-08-23

Legal Events

Date	Code	Title	Description
2012-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
JO2448B1 (en)	2008-10-09	Topical pharmaceutical compositions for the treatment of dermatitis
ZA89233B (en)	1990-09-26	Topical metronidazole formulations and therapeutic uses thereof
WO2003018619A3 (en)	2003-10-30	Antimicrobial and anti-inflammatory peptides
IL128205A (en)	2003-09-17	Indane derivatives and pharmaceutical compositions containing the same
EP1575598B8 (en)	2007-11-21	Pharmaceutical compositions comprising a combination of calcitriol and clobetasol propionate
AU2745700A (en)	2000-08-18	A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
AU3142195A (en)	1996-05-15	Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
WO2000027381A3 (en)	2000-11-23	Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
MXPA04000654A (es)	2004-03-19	Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
AU2588297A (en)	1997-10-29	Liposome-based topical vitamin d formulation
JO2434B1 (en)	2008-04-17	New retinoids to treat emphysema
IL172773A0 (en)	2006-04-10	Formulations for the treatment of arhritis conditions
CA2157836A1 (en)	1996-03-09	L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
AU3902299A (en)	1999-12-30	Methods of treating microbial infection and therapeutic formulations therefor
WO2007065289A3 (en)	2007-08-02	4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
FR2804286B1 (fr)	2002-09-06	Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
PT1492773E (pt)	2009-05-07	Compostos de 4-(heterociclilo)-benzenossulfoximinapara o tratamento da inflamação
BR9712141A (pt)	1999-08-31	Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
PL1867322T3 (pl)	2010-06-30	Kompozycja do zastosowania miejscowego w leczeniu łuszczycy
DE602005024959D1 (de)	2011-01-05	Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen
AR042476A1 (es)	2005-06-22	Composiciones farmaceuticas que comprenden una asociacion de calcitriol y de un propionato de clobetasol
MXPA05001469A (es)	2005-06-06	Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.
WO1998013009A3 (de)	1998-05-14	Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
MX2007011486A (es)	2007-11-20	Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.
EP1875916A3 (en)	2008-01-23	Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate